These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24720)

  • 1. Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1978 Apr; 30(4):257-9. PubMed ID: 24720
    [No Abstract]   [Full Text] [Related]  

  • 2. Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat.
    Jones DL; Mogenson GJ; Wu M
    Neuropharmacology; 1981 Jan; 20(1):29-37. PubMed ID: 6261181
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
    Costall B; Fortune DH; Hui SC; Naylor RJ
    Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats.
    Hetey L; Drescher K
    Neuropharmacology; 1986 Oct; 25(10):1103-9. PubMed ID: 2878387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of monoamines on the dl-tetrahydropalmatine-induced inhibition of single-unit activity in the nucleus accumbens].
    Liu GQ; Wu HQ; Xie L; Mei XY
    Yao Xue Xue Bao; 1985 Jul; 20(7):500-4. PubMed ID: 2869636
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI).
    Costall B; Hui SC; Naylor RJ
    Neuropharmacology; 1979 Jul; 18(7):605-9. PubMed ID: 492482
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM; Mogenson GJ
    Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.
    Van Ree JM; Wolterink G
    Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
    Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
    Blaha CD; Lane RF
    Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
    Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
    Di Chiara G; Imperato A
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5274-8. PubMed ID: 2899326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.